Corbus Pharmaceuticals Holdings Inc. (CRBP) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Corbus Pharmaceuticals Holdings Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$4.25
+2.41% today
Market cap
$80M
Overall quality
44/100
Kronos AI 30-day
+101.8%
8 of 8 simulated paths end higher
Corbus Pharmaceuticals Holdings Inc. (CRBP) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $80M. It trades at $4.25, up 2.41% today. Its overall quality score is 44 out of 100, ranked against the whole US market. 7 analysts' average target of $36.67 implies +762.8% from today's price. Kronos AI's 30-day forecast is +101.8% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $36.67 |
| Low – high | $30.00 – $48.00 |
| Analysts | 7 |
| Upside to average | +762.8% |
Kronos AI 30-day forecast
| Expected close | $8.37 (+101.8%) |
| Likely range | +78.9% … +118.3% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 38 |
| Solvency | 60 |
| Growth | 34 |
| Overall | 44 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.